Tachibana provided third quarter 2025 guidance of total company revenue in the range of $12 million to $14 million and pharma test/services revenue in the range of $11 million to $13 million.

Paul J. Diaz, President and Chief Executive Officer: "As we executed strategic initiatives to accelerate growth during the recent stages of the COVID-19 pandemic, we saw a significant recovery in test ...

The company raised 2025 total revenue guidance to $310 million–$320 million. Stokes explained that “our normalized revenue growth range in 2025 would be approximately 21% to 26%” when excluding ...

Allen Career Institute’s net profit fell sharply in fiscal 2025 despite steady revenue. The drop is due to a shift away from its Kota base and heavy investment in digital platforms, new centres, and ...

Sales of new productions and developments came in at €2.0 million, down sharply due to the halt in order from international streaming platforms, as well as the low level of deliveries for proprietary ...

Net sales were a record $22.3 million, up from $20.3 million in the fourth quarter of fiscal 2022. GAAP net income was a record $6.1 million, or $0.21 per diluted share, up from GAAP net income of ...

Have you assessed how the international operations of Coca-Cola (KO) performed in the quarter ended March 2024? For this world's largest beverage maker, possessing an expansive global footprint, ...

Lee Enterprises reported a 5% increase in total digital revenue and a 14% rise in digital-only subscriptions for Q1 2025. Lee Enterprises, Incorporated has reported a 5% year-over-year increase in ...

What is 23andMe+ Total Health? 23andMe+ Total Health is a new annual membership that expands on the 23andMe DNA test to include comprehensive blood tests and health screenings. The brand says the ...